EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chrysin Synergistically Reverses Chemoresistance in Ovarian Cancer by Inhibiting Epithelial-Mesenchymal Transition

Nan Zhang, Xiaoyuan Hao, Chunying Zhuang, Chenjing Zhu, Sicong Liu, Xiaoyuan Lu, Yuxian Xie, Ke’er Jiang, Mengyu Li, Jialin Zhu, Ting Luo, Xiaoxiao Liu und 1 weitere

Clinical and Experimental Obstetrics & Gynecology · 19.10.2026 · 53 (10)

DOI: 10.31083/ceog52655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Obstetrics & Gynecology, online erschienen am 19.10.2026. Verfasst von Nan Zhang und 12 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Key Project of Jiangsu Provincial Health Commission, “Pairing Assistance” Research Project of the Affiliated Hospital of Xuzhou Medical University, Xuzhou City Clinical Technical Backbone Training Program.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ovarian cancer (OC), a lethal gynecological malignancy, frequently develops resistance to cisplatin, which significantly contributes to chemotherapy failure. Chrysin, a natural flavonoid, has exhibited anti-tumor and chemosensitizing effects, but evidence specific to OC remains limited.

Methods

Parental SKOV3 and CAOV3 cells were treated with chrysin alone to assess cell viability (cell counting kit-8 (CCK-8) and colony formation assays) and apoptosis (flow cytometry). The synergistic effects of chrysin combined with cisplatin were evaluated using CCK-8 assays and CompuSyn 1.0 software (ComboSyn, Inc., Paramus, NJ, USA). Subsequently, two cisplatin-resistant sublines (SKOV3/DDP and CAOV3/DDP) were generated by gradually increasing cisplatin exposure. Changes in epithelial-mesenchymal transition (EMT) protein levels between parental and resistant cells were compared using Western blotting, followed by repeated viability (CCK-8), colony formation, Transwell migration, and apoptosis (flow cytometry) assays in resistant lines. Transcriptome sequencing was performed to identify differentially expressed genes. Additionally, EMT-related proteins (E-cadherin, N-cadherin, vimentin, and Snail1) and components of the nuclear factor kappa B (NF-κB) pathway (p-P65, P105/P50, p-IKKα/β, and p-IκBα) were analyzed by Western blotting. A rescue experiment using the NF-κB activator phorbol 12-myristate 13-acetate (PMA) confirmed the involvement of the NF-κB pathway.

Results

Chrysin inhibited proliferation, induced apoptosis, and synergistically enhanced the efficacy of cisplatin in both parental and cisplatin-resistant OC cells. Mechanistically, chrysin suppressed the NF-κB pathway, consequently reversing EMT associated with cisplatin resistance.

Conclusions

Chrysin synergistically enhances cisplatin efficacy against OC, including cisplatin-resistant cells, by modulating the NF-κB/EMT pathway. These findings suggest that chrysin could serve as a promising strategy for overcoming cisplatin resistance and merit clinical investigation.

Förderung

  • Medical Research Key Project of Jiangsu Provincial Health Commission
  • “Pairing Assistance” Research Project of the Affiliated Hospital of Xuzhou Medical University
  • Xuzhou City Clinical Technical Backbone Training Program
  • Young Talent Program of The Affiliated Hospital of Xuzhou Medical University
  • Advanced Program of The Affiliated Hospital of Xuzhou Medical University
  • Medical Research Project of Jiangsu Provincial Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, N., Hao, X., Zhuang, C., Zhu, C., Liu, S., Lu, X., Xie, Y., Jiang, K., Li, M., Zhu, J., Luo, T., Liu, X., & Chen, B. (2026). Chrysin Synergistically Reverses Chemoresistance in Ovarian Cancer by Inhibiting Epithelial-Mesenchymal Transition. Clinical and Experimental Obstetrics & Gynecology, 53(10). https://doi.org/10.31083/ceog52655

Vancouver

Zhang N, Hao X, Zhuang C, Zhu C, Liu S, Lu X, et al. Chrysin Synergistically Reverses Chemoresistance in Ovarian Cancer by Inhibiting Epithelial-Mesenchymal Transition. Clinical and Experimental Obstetrics & Gynecology. 2026;53(10). doi:10.31083/ceog52655

BibTeX
@article{Zhang2026,
  author = {Zhang, Nan and Hao, Xiaoyuan and Zhuang, Chunying and Zhu, Chenjing and Liu, Sicong and Lu, Xiaoyuan and Xie, Yuxian and Jiang, Ke’er and Li, Mengyu and Zhu, Jialin and Luo, Ting and Liu, Xiaoxiao and Chen, Buze},
  title = {Chrysin Synergistically Reverses Chemoresistance in Ovarian Cancer by Inhibiting Epithelial-Mesenchymal Transition},
  journal = {Clinical and Experimental Obstetrics & Gynecology},
  year = {2026},
  volume = {53},
  number = {10},
  doi = {10.31083/ceog52655}
}
Kostenlos starten →